Problem statement: Answer the MCQ question.
Question: Which drug exhibits a -16.787% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
a. N/C(=N\OC(=O)CCC1CCCC1)c1ccccc1
b. COc1ccc(Cc2nnc(SCC(=O)N(c3ccccc3)C(C)C)n(N)c2=O)cc1
Answer: b. COc1ccc(Cc2nnc(SCC(=O)N(c3ccccc3)C(C)C)n(N)c2=O)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
COc1ccc(Cc2nnc(SCC(=O)N(c3ccccc3)C(C)C)n(N)c2=O)cc1
COc1ccc(Cc2nnc(SCC(=O)N(c3ccccc3)C(C)C)n(N)c2=O)cc1
2-[[4-amino-6-[(4-methoxyphenyl)methyl]-5-oxo-1,2,4-triazin-3-yl]sulfanyl]-N-phenyl-N-propan-2-ylacetamide